年會資訊

  1. 歐洲放射腫瘤年會 ESTRO 38, 26-30 April, 2019, Milan, Italy.
  2. PTCOG 58, June 10-15, 2019, The Christie Proton Therapy Center, NHS, Manchester, UK.
  3. 美國放射腫瘤年會 The 61th ASTRO Annual Meeting, 15-18 Sep, 2019, Illinois, Chicago, USA.
 

研討會論文 

  1. Chen, Y.J. et al.Sequential Blockade of PD-1 and PD-L1 Causes Fulminant Cardiotoxicity – from Case Report to Mice Model Validation, (ESMO 2018 Poster) Annals of Oncology (2018) 29 (suppl_8): viii400-viii441. 10.1093/annonc/mdy288
  2. Dai, K.Y. et al. Risk-Based Optimization of Intensity-Modulated Radiation Therapy Guideline for Post-Operative Oral Cavity Cancer, (2018 ASTRO Poster) International Journal of Radiation Oncology • Biology • Physics , Volume 102 , Issue 3 , e237 - e238
  3. Chen, Y.S. et al. Mitomycin C Enhances Radiation Effect against Rectal Cancer with Favorable Modulation of Tumor Microenvironment, (2018 ASTRO Poster) International Journal of Radiation Oncology • Biology • Physics , Volume 102 , Issue 3 , e162
  4. Lee, J. et al. Image-Guided Study of Interfraction and Intrafraction Set-up Variability and Margins in Reverse Semi-Decubitus Breast Radiation Therapy, (2018 ASTRO Oral Presentation) International Journal of Radiation Oncology • Biology • Physics , Volume 102 , Issue 3 , S132
  5. Lee, J. et al. Skeletal Muscle Loss During Definitive Chemoradiotherapy is Negatively Associated with Outcomes in Locally Advanced Cervical Cancer, (2018 ASTRO Oral Presentation) International Journal of Radiation Oncology • Biology • Physics , Volume 102 , Issue 3 , S85

SCI論文發表

  1. Jie Lee*, C.L. Chang, C.B. Lin, Skeletal Muscle Loss is an Imaging Biomarker of Outcome After Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer. Clin Cancer Res. 2018 Oct 15;24(20):5028-5036. (IF= 10.199; Ranking: 5.40% (12/222) in Oncology).
  2. Chang CW, Liu CY, Lee HC, Chen YJ*, Lactobacillus casei Variety rhamnosus Probiotic Preventively Attenuates 5-Fluorouracil/Oxaliplatin-Induced Intestinal Injury in a Syngeneic Colorectal Cancer Model. Front Microbiol. 2018 May (Article in Press) (IF= 4.019; Ranking: 24.80% (31/125) in Microbiology)
  3. Liu YM, Liu YK, Huang PI, Tsai TH, Chen YJ*.Antrodia cinnamomea mycelial fermentation broth inhibits the epithelial-mesenchymal transition of human esophageal adenocarcinoma cancer cells. Food Chem Toxicol. 2018 Article in Press (IF= 3.778; Ranking: 6.20% (8/129) in FOOD SCIENCE & TECHNOLOGY)
  4. Jie Lee*, M.H. Wu, Y.J Chen* et al.Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes. Gynecol Oncol. 2018 Feb;148(2):291-98. (IF= 4.959; Ranking: 7.50% (6/80) in Obstetrics & Gynecology)
  5. Liu CK, Chen CA, Lee TY, Chang HH, Liao HF, Chen YJ*.Rice protein prolamin promotes anti-leukemia immunity and inhibits leukemia growth in vivo. Food Chem Toxicol. 2018 Feb;112:435-440. (IF= 3.778; Ranking: 6.20% (8/129) in FOOD SCIENCE & TECHNOLOGY)
  6. Jie Lee, M.H. Wu*, Y.J Chen* et al.Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience. Gynecol Oncol. 2017 Jul;146(1):20-26. (IF= 4.959; Ranking: 7.50% (6/80) in Obstetrics & Gynecology)
  7. Jie Lee, Y.J. Chen*, M.H. Wu, Development of delineation for the left anterior descending coronary artery region in left breast cancer radiotherapy: An optimized organ at risk. Radiother Oncol. 2017 Mar;122(3):423-430. (IF= 4.817; Ranking: 8.06% (10/124) in Radiology, nuclear medicine & medical imaging)
  8. Chen JC et al. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model. Oncotarget. 2016 Dec 20;7(51):85450-85463. (IF= 5.008; Ranking: 16.9% (36/213) in Oncology)
  9. Fu SL, Lin CC, Hsu ML, Liu SH, Huang YC, Chen YJ*. CCL-34, a synthetic toll-like receptor 4 activator, modulates differentiation and maturation of myeloid dendritic cells. OncoTarget. 2016 Feb. (IF= 6.359; Ranking: 9.95% (21/211) in Oncology)
  10. Lee J, Lin J-B, Sun F-J et al. Dosimetric predictors of acute haematological toxicity in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy. The British journal of radiology. 2016;89:1066
  11. Chang CH, Liu SY, Chi CW, Yu HL, Chang TJ, Tsai TH, Lee TW, Chen YJ*. External beam radiotherapy synergizes 188Re-liposome against human esophageal cancer xenograft and modulates 188Re-liposome pharmacokinetics. Int J Nanomed. 2015 May; 10: 3641-3649. (IF= 4.383; Ranking: 11.76% (30/255) in Pharmacology & Pharmacy)
  12. Hui-Wen Lin, Shiyng Yu Lin, Wei Li Lin, Wei Zer Lin, Yuen-Liang Lai*. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncology 2011;12(9):900-904. (通訊作者)
  13. Liu SH, Chao KS, Leu YS, Lee JC, Liu CJ, Huang YC, Chang YF, Chen HW, Tsai JT, Chen YJ*. Guideline and preliminary clinical practice results for dose specification and target delineation for postoperative radiotherapy of oral cavity cancer. Head Neck-J Sci Spec. 2015 Jul; 37(7):933-939. (IF= 2.641; Ranking: 9.09% (4/44) in Otorhinolaryngology)